Abstract Chitosan derivative was successively synthesized by initial preparation of acyl thiourea reagent using ammonium thiocyanate and making it to react with at primary amino groups of chitosan and then reduced to yield Thiolated Chitosan. Due to the formation of disulphide bonds with mFucus glycoproteins, mucoadhesiveness is augmented. The thiol groups were then quantified using Ellman's reagent. The derivatives inherit good swelling property in neutral and alkaline media. The different derivatives containing thiol groups were formulated into tablets using reference drug for evaluation. The Thiolated Chitosan display in situ gelling features due to the pHdependent (alkaline pH) formation of inter-molecular disulphide bonds which makes the application of Thiolated Chitosan on intestinal mucosa and can guarantee prolonged controlled release of embedded therapeutic ingredients. 
Introduction
Chitosan is a well-known polymer of study because of its biocompatibility, biodegradability and drug-absorption enhancement. Chitosan is a multifunctional polymer but it is found to devoid of pharmaceutical use because of poor or no water solubility and alkaline solubility was far impossible.
Chitosan is obtained by deacetylation of chitin resulting the free amino group that can make it be policationic (Champagne, 2008) . Chitosan has proven to have mucoadhesive properties due to electrostatic interactions between positively charged chitosan and negatively charged mucosal surface. Thus, in a context, Chitosan has one primary amino group and two free hydroxyl groups for each monomer. Free amino group in chitosan is positively charged subsequently react with the mucus are negatively charged (Irene and Christine, 2007) .
Various modifications have been made to the existing mucoadhesive polymer resulting in a better mucoadhesive properties. One modification is done is with the immobilization of thiol groups to mucoadhesive polymer so as to form disulphide bonds with cysteine-rich subdomains of mucus glycoproteins. Unlike the first generation mucoadhesive polymers attached to the mucus gel layer through non-covalent bonding, the new generation of mucoadhesive polymers capable of forming covalent bonds to the layer of mucus (Bowman and Leong, 2006) .
The literature states that acylation of chitosan at amino position results in increase in its water solubility 3. Further, some chitosan conjugates with thiol containing moieties have shown promising swelling property in alkaline pH (Irene and Christine, 2007; Sreenivas and Pai, 2008) . This article deals with synthesis of some novel derivatives of chitosan possessing thiol functional group obtained in stepwise reaction. The derivatives were prepared by applying a simple thiouride synthetic pathway which is then further reduced to form a Thiolated Chitosan derivative. The derivative shows a good mucoadhesion, water solubility, swelling in alkaline pH which can be used for controlled release for intestinal release. The properties of the derivatives were assessed with various physiochemical tests as Swelling Index, Mucoadhesive strength, thiol content, structural elucidation with NMR, etc. The derivatives retain the acid solubility inherited from the precursor and show enhanced new properties which further increases it usage ability in pharmaceuticals. The derivatives thus have good pharmaceutical and biological properties to be used as a polymer in intestinal delivery of drug.
Materials and methods

Materials
Chitosan (medium molecular mass: 400 KDa; degree of deacetylation: 83-85%) was purchased from Research Laboratories, Acylchlorides, ammonium thiocyanate, Elman's Reagent were obtained from Research Lab and aluminium isopropoxide was procured from SIGMA. All chemicals were of analytical grade. NMR analysis was performed at IIT (Powai).
Preparation of acylthiocyanate reagent
The solution of ammonium thiocyanate (0.011 mol) in dry acetone (25 ml) was prepared. Benzoyl chloride (0.01 mol) was added slowly in above solution with stirring. The reaction mixture was subjected to microwave irradiation for 3 mins at 560 W power to yield an acylthiocyanate reagent (Kumaraswamy et al., 2006) .
Synthesis of acylthiouride of chitosan
A solution of chitosan in 2%AcOH/MeOH (50 ml) was added slowly to the above solution so as to maintain reflux condition. After the addition was complete, the mixture was stirred for 90 min at room temperature, which is separated as solid precipitate on pouring in NaOH solution (pH 10) Zhong et al., 2008; Champagne, 2008 .
Synthesis of Thiolated Chitosan derivative
The above precipitate was washed with acetone thoroughly to remove the traces of acylthiocyanate. The product was then treated with aluminium isopropoxide in Isopropanol which reduces the thioketone group from acylthiouride to form the thiol resulting in the formation of Thiolated Chitosan. The aluminium isopropoxide in isopropanol solution is as specific reducing agent for ketones (Finar, 2006) (Fig. 1) .
Procedure for quantification of sulfhydryl groups
A dilution buffer (0.1 M Sodium phosphate, 1 mM EDTA, pH 8.0) and DTNB [(5,5 0 -dithio-bis-(2-nitrobenzoic acid)] working solution were prepared initially. The solutions were stored at +4°C. 4 mg of DTNB was dissolved in 1 ml dilution buffer. A set of Sulfhydryl standard (Cysteine HCl) with sample dilution buffer (or distilled water) was prepared. Cysteine HCl (26.34 mg) was dissolve in the media to prepare 1.5 mM solution, serial dilutions 1.25 mM, 1.0 mM, 0.75 mM, 0.5 mM and 0.25 mM were prepared and were used immediately. Following components were added subsequently to the test tubes: 250 ll Sample/Standard 2.5 ml dilution buffer 50 ll DTNB reagent
The resulting solution was incubated for 15 min and absorbance was measured at the wavelength of 412 nm and concentration of Sulfhydryl group was determined using Cysteine as standard solution. Molar extinction coefficient at 412 nm of R: -C6H5, -C6H4Cl, -C6,H4NH2, C3H4 DTNB is 14,150 M À1 cm À1 (Irene and Christine, 2007; Alvear et al., 1989) (Table 1 ).
Swelling Index
Swelling index of the synthesized derivative was determined by soaking 150 mg flat faced 8 mm tablet in 6 ml of water in a Petri-dish. Initial and final weights of the tablets were recorded (Table 2) .
Swelling index was calculated by using following formula:
Swelling index ¼ Final weight À initial weight=Final weight Â 100
Solubility test
The solubility of the copolymers was tested in several organic solvents, distilled water as well as in 0.1 M phosphate buffer (pH 4.0), 0.1 M phosphate buffer (pH 7.0) and DMSO. The samples were soaked in each solvent at the concentration of 5 mg/ml (Gorochovceva and Kulbokaite, 2004) (Table 3) .
Mucoadhesivity assessment
Recently, it has been shown that polymers with thiol groups provide much higher adhesive properties than polymers generally considered to be mucoadhesive. The enhancement of mucoadhesion can be explained by the formation of covalent bonds between the polymer and the mucus layer which are stronger than non-covalent bonds. This theory was supported by the results of assessment of Mucoadhesive strength demonstrated a positive correlation between the degree of modification with thiol bearing moieties and the adhesive properties of the polymer (Sreenivas and Pai, 2008; Deshmane et al., 2009) . For the measurement of the Mucoadhesive strength, the pure polymer was taken and the disc of 150 mg was prepared by using 8 mm die on the rotary compression machine. After that the tablet was removed and used for the measurement of the mucoadhesive strength (Fig. 4) .
Thiol derivative as controlled release matrix
Thiolated Chitosan represents, primarily due to its mucoadhesive properties, a valuable tool for non-invasive drug delivery. The longer residence time of formulations based on mucoadhesive polymers at the absorption site is believed to contribute to an increased absorption rate of the incorporated drug. However, such an enhanced bioavailability can be achieved only if a controlled release of the active agent out of the formulation is provided. Thiolated Chitosans also display, besides their strong mucoadhesive and permeation enhancing properties, excellent cohesive properties. The cohesion and stability of a drug delivery system over the intended duration of drug liberation is often a substantial requirement for a controlled release. The usefulness of Thiolated Chitosans as carrier matrices for controlled drug release was demonstrated with model drug as Amodiaquine (Sreenivas and Pai, 2008) (Table 4) .
Results and discussion
Five thiolated derivatives were synthesized viz; N-Benzoyl thiolurea derivative, N-(3-oxybenzoyl) thiolurea derivative, N-(2-chloro-4-oxybenzoyl) thiolurea derivative, N-(4-aminobenzoyl) thiolurea derivative and N-Itaconoyl thiolurea derivative. The IR spectra (Fig. 2 ) and NMR spectra (Fig. 3) were assessed for structural confirmation. The thiolated derivatives of chitosan possess a distinctive smell with characteristic pale yellowish colour and fibrous appearance. The derivatives are soluble in acid solution and if added to water or alkaline media it disperses to form a high viscosity gel like dispersion. Due to bulkier aromatic group it provided hindrance to the thiol group to immobilize on primary amino group of chitosan. The resultant thiolated polymer derivatives have shown good swelling property and enhanced mucoadhesive strength due to the intermolecular disulphide linkage between the polymer and mucosa (Sreenivas and Pai, 2008; Deshmane et al., 2009) (Fig. 4) . The mucoadhesive test was assessed by measuring the contact time of chitosan derivatives and a sample intestinal mucosa. Because of its mucoadhesive properties the resultant thiolated polymer derivatives have shown prolong residence time of the dosage form in the small intestine, the permeation enhancing effect, Sustained drug release and good oral bioavailability of various poorly absorbed drugs were improved.
Also the derivatives have shown a promising sustained release property ( Figure 5 ). The swelling behaviours of the polymer were assessed using a simple analysing method of petri plate by checking the amount of water absorbed by the tablet during the resident time (Deshmane et al., 2009) (Table 2) .
The proposed release pattern of the polymer was assessed by transforming the polymer in tablet formulation and incorporating a model drug into it. The tablet was made to reside in a dissolution test media and a timely sampled solution from the dissolution jars revealed a controlled release of drug over a specified period of time (Sreenivas and Pai, 2008) . 
